CME webinar: Hepatitis C, B, and HIV: Screening and Management
Mar. 2024Education/Webinars
Please join us for a live, continuing medical education (CME)-accredited webinar on Wednesday, May 1, from noon to 1 p.m. The webinar will provide an overview of hepatitis C, B, and HIV screening and management. During this presentation, our expert will:
Presenter:
Nicholas DeGregorio, MD, MMM, FACP,
Associate Vice President, Medicaid Medical Services, UPMC Health Plan
Register now.
This webinar will be recorded.
This activity is approved for AMA PRA Category 1 Credit™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
This activity has been designated as and meets the Pennsylvania licensure requirement for Patient Safety-Risk Management Credit. It is the responsibility of the learner to maintain the educational presentation or conference agenda as evidence, if needed for audit purposes.
Provider is responsible for verifying CME eligibility.
- Review the prevalence, trends, and screening recommendations for hepatitis B, C, and HIV.
- Discuss recommended screening tests and the interpretation of the results.
- Review the management of hepatitis C and the role of primary care in its treatment.
- Discuss considerations with hepatitis C, B, and HIV coinfections.
Presenter:
Nicholas DeGregorio, MD, MMM, FACP,
Associate Vice President, Medicaid Medical Services, UPMC Health Plan
Register now.
This webinar will be recorded.
This activity is approved for AMA PRA Category 1 Credit™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
This activity has been designated as and meets the Pennsylvania licensure requirement for Patient Safety-Risk Management Credit. It is the responsibility of the learner to maintain the educational presentation or conference agenda as evidence, if needed for audit purposes.
Provider is responsible for verifying CME eligibility.
Recent Announcements
Voluntary nationwide recall: Tyenne (Fresenius – August 2026)
Fresenius Kabi is recalling one lot, lot 16UI07, of Tyenne® (tocilizumab-aazg) Injection 400 mg/20 mL (20 mg/mL) 20 mL vials. Tyenne is used for the treatment of certain arthritis conditions.Aug. 2026Pharmacy Updates
Provider OnLine Login Changes for UPMC Employees
UPMC employees will now use their email address to access Provider OnLine. Authentication will occur through their UPMC credentials and network connections. If your UPMC email address has changed since joining the organization, you should use the email address associated with your Microsoft Teams chat account when logging in to Provider OnLine.Aug. 2026Important Notices
CME Webinar: Lifestyle Medicine in Practice: Evidence‑Based Strategies for Chronic Disease Care
Please join us for a live, CME-accredited webinar on Wednesday, Sept. 23 from noon to 1 p.m., that will provide an overview on lifestyle medicine. Participants will learn how to integrate six core domains—nutrition, physical activity, sleep, stress management, avoidance of risky substances, and social connection—into routine care using practical tools such as brief counseling, motivational interviewing, and team-based strategies.Aug. 2026Education/Webinars